PReS-FINAL-2029: Long-term follow-up of patients with juvenile idiopathic arthritis (JIA) in a single center: a systematic chart review by BE Bica et al.
POSTER PRESENTATION Open Access
PReS-FINAL-2029: Long-term follow-up of
patients with juvenile idiopathic arthritis (JIA)
in a single center: a systematic chart review
BE Bica*, DS Bastos, TA Nogueira
From 20th Pediatric Rheumatology European Society (PReS) Congress
Ljubljana, Slovenia. 25-29 September 2013
Introduction
Juvenile idiopathic arthritis (JIA) is the most common
chronic pediatric rheumatic disease, affecting 4 of every
1,000 children worldwide. It may cause joint damage,
persistent pain and retardation of normal growth, which
eventually may lead to long-term disability and
decreased quality of life. Treatment aims disease control
and induction of remission, preventing joint damage
and unfavorable outcomes.
Objectives
To determine the disease outcome of JIA patients fol-
lowed in a single center in Rio de Janeiro, Brazil.
Methods
JIA patients registered to the Rheumatology Unit of a
University Hospital from 2000 to 2012, first seen before
age of 16, and with a follow-up of at least 5 years had
their chart data reviewed in the search for information,
including: gender, subtype of JIA, age of diagnoses,
duration of disease, presence of uveitis, surgery, medica-
tion used.
Results
Ninety-four patients were identified and among these
patients, 53 (56.38%) were female and 41 (43.62%) were
male with age between nine and forty years. The average
duration of disease was 14.7 years, with an average diag-
noses gap of one year and five months. Onset subtypes
of JIA were: oligoarticular in 29 (30.85%), systemic in 23
(24.47%), entesites-related arthritis in 14 (14.89%), poly-
articular RF negative in 14 (15.96%), polyarticular RF
positive in 8 (8.51%), psoriatic arthritis in 5 (5.32%).
Remission of disease according to Wallace et al (2004)
was seen in 73 (77.66%) patients, of which 39 (53.42%)
were currently using medication (methotrexate 66,67%,
NSAID 43.59%, corticosteroid 41.03%, biological drugs
38.46%, antimalarial drugs 10.26%, leflunomide 7.69%,
azathioprine 5.13%, ciclosporin 2,56%). Uveitis occurred
in 13 (13.83%) patients. Among the 15 (15.96%) patients
who underwent surgery, eight (8.51%) patients had
arthroplasty and two (2.13%) had knee tenotomy. Five
patients (5.32%) had ophthalmic surgery.
Conclusion
The study showed remission of disease in 73 (77.66%)
patients, diagnosed as oligoarticular onset in 22.31% and
systemic in 19.27%. Of those in remission, 39 (39.53%)
were currently using some medication. The 21 patients
(22.34%) who still presented active arthritis, 7.33% had




Published: 5 December 2013
doi:10.1186/1546-0096-11-S2-P42
Cite this article as: Bica et al.: PReS-FINAL-2029: Long-term follow-up of
patients with juvenile idiopathic arthritis (JIA) in a single center: a
systematic chart review. Pediatric Rheumatology 2013 11(Suppl 2):P42.
Rheumatology, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Bica et al. Pediatric Rheumatology 2013, 11(Suppl 2):P42
http://www.ped-rheum.com/content/11/S2/P42
© 2013 Bica et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
